A Double-Blind, Randomized Comparison Study between Zytux™ vs MabThera® in Treatment of CLL with FCR Regimen: Non-Inferiority Clinical Trial.Gholamreza Toogeh, Shadi Sadat Alizadeh Fard, Vahid Fallahazad et al.|PubMed|2018Cited by 17
Efficacy and Safety of Proposed Bevacizumab Biosimilar BE1040V in Patients With Metastatic Colorectal Cancer: A Phase III, Randomized, Double-blind, Noninferiority Clinical TrialHamid Rezvani, Sina Salari, Mohsen Rajaeinejad et al.|Clinical Therapeutics|2020Cited by 15